Health Care & Life Sciences » Biotechnology | Sirona Biochem Corp.

Sirona Biochem Corp. | Income Statement

Fiscal year is November-October. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
207.70
8.00
360.50
5.50
1,278.70
Cost of Goods Sold (COGS) incl. D&A
104.30
-
-
-
-
-
Gross Income
104.30
-
-
-
-
-
SG&A Expense
3,045.70
4,244.00
3,613.70
3,364.20
2,497.20
2,559.90
EBIT
3,149.90
4,062.80
-
3,152.20
2,677.60
1,281.20
Unusual Expense
-
-
-
-
1,943.80
-
Non Operating Income/Expense
235.60
314.60
16.30
1.40
108.00
45.30
Interest Expense
78.50
80.10
86.90
40.10
145.60
226.80
Pretax Income
2,992.70
3,828.30
3,888.50
3,193.00
4,659.00
1,462.60
Income Tax
208.10
302.60
228.60
218.30
198.60
189.30
Consolidated Net Income
2,784.60
3,525.70
3,659.90
2,974.80
4,460.40
1,273.20
Net Income
2,784.60
3,525.70
3,659.90
2,974.80
4,460.40
1,273.20
Net Income After Extraordinaries
2,784.60
3,525.70
3,659.90
2,974.80
4,460.40
1,273.20
Net Income Available to Common
2,784.60
3,525.70
3,659.90
2,974.80
4,460.40
1,273.20
EPS (Basic)
0.03
0.03
0.03
0.02
0.03
0.01
Basic Shares Outstanding
92,288.20
117,781.40
138,341.60
159,465.30
159,862.30
171,771.20
EPS (Diluted)
0.03
0.03
0.03
0.02
0.03
0.01
Diluted Shares Outstanding
92,288.20
117,781.40
138,341.60
159,465.30
159,862.30
171,771.20
EBITDA
3,045.70
4,036.30
3,605.70
3,003.70
2,491.80
1,281.20
Non-Operating Interest Income
0.20
-
0.70
0.70
-
-

About Sirona Biochem

View Profile
Address
595 Burrard Street
Vancouver British Columbia V7X 1L3
Canada
Employees -
Website http://www.sironabiochem.com
Updated 07/08/2019
Sirona Biochem Corp. engages in the development of diabetes therapeutics, skin depigmenting, and anti-aging agents for cosmetic use, biological ingredients, and cancer vaccine antigens. It also involves in utilizing a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules. The company was founded by Howard Jarman Verrico on October 19, 2006 and is headquartered in Vancouver, Canada.